fda bans semaglutide Compounded & Tirzepatide 2025: Safe Use Guide FDA Warns on Certain Forms

Retatrutide appears to produce the fastest weight loss trajectory, with participants in Phase 2 trials losing 24.2% of body weight in just 48 weeks, a pace that outstrips semaglutide and tirzepatide over comparable timeframes

Krakauer, M

Foods to avoid (GLP-1 inhibitors) Refined sugars: Blood sugar spikes insulin resistance decreased GLP-1 Ultra-processed foods: Low in fiber, destroy the gut microbiota Trans fats: Intestinal inflammation less GLP-1 Excessive alcohol: Disrupts digestive hormones Artificial sweeteners: Disrupt satiety signals Consumption patterns: when and how to eat to maximize GLP-1 Beyond what you eat, how you eat directly influences your GLP-1

To appreciate the significance of the retatrutide phase 2 findings, it is helpful to compare them with the efficacy data for currently approved weight management medicines in the UK